Search research articles
Contact Us
Filters
Showing results (31-40 of 111) with videos related to
Page
of 12
Sort By:
Frontiers in Neurology
|
November 21, 2022
The not so hidden impact of interictal burden in migraine: A narrative review
Maurice Vincent, Lars Viktrup, Robert A Nicholson, et al.
Journal of Pain Research
|
June 18, 2020
Nerve Growth Factor Signaling and Its Contribution to Pain
Philip A Barker, Patrick Mantyh, Lars Arendt-Nielsen, et al.
European Urology
|
February 3, 2012
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial
Matthias Oelke, François Giuliano, Vincenzo Mirone, et al.
The Journal of Sexual Medicine
|
June 21, 2013
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies
Hartmut Porst, Claus G Roehrborn, Roberta J Secrest, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 29, 2005
Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety
Daniel J Hurley, Catherine L Turner, Ilker Yalcin, et al.
BJU International
|
September 9, 2014
Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia – integrated data from 1,499 study participants
John Curtis Nickel, Gerald B Brock, Sender Herschorn, et al.
The Journal of Urology
|
January 22, 2014
Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
Claus G Roehrborn, Christopher Chapple, Matthias Oelke, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 2, 2015
Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo
Claus G Roehrborn, Adolfo Casabé, Sidney Glina, et al.
Postgraduate Medicine
|
July 12, 2021
Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies
Yvonne D'Arcy, Patrick Mantyh, Tony Yaksh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 26, 2015
Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analyses of data pooled from three randomized, double-blind, placebo-controlled studies
Osamu Nishizawa, Masaki Yoshida, Masayuki Takeda, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 111) with videos related to
Sort By:
Page
of 12
Frontiers in Neurology
|
November 21, 2022
The not so hidden impact of interictal burden in migraine: A narrative review
Maurice Vincent, Lars Viktrup, Robert A Nicholson, et al.
Journal of Pain Research
|
June 18, 2020
Nerve Growth Factor Signaling and Its Contribution to Pain
Philip A Barker, Patrick Mantyh, Lars Arendt-Nielsen, et al.
European Urology
|
February 3, 2012
Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial
Matthias Oelke, François Giuliano, Vincenzo Mirone, et al.
The Journal of Sexual Medicine
|
June 21, 2013
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies
Hartmut Porst, Claus G Roehrborn, Roberta J Secrest, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
September 29, 2005
Duloxetine for the treatment of stress urinary incontinence in women: an integrated analysis of safety
Daniel J Hurley, Catherine L Turner, Ilker Yalcin, et al.
BJU International
|
September 9, 2014
Proportion of tadalafil-treated patients with clinically meaningful improvement in lower urinary tract symptoms associated with benign prostatic hyperplasia – integrated data from 1,499 study participants
John Curtis Nickel, Gerald B Brock, Sender Herschorn, et al.
The Journal of Urology
|
January 22, 2014
Effects of tadalafil once daily on maximum urinary flow rate in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
Claus G Roehrborn, Christopher Chapple, Matthias Oelke, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 2, 2015
Treatment satisfaction and clinically meaningful symptom improvement in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: Secondary results from a 6-month, randomized, double-blind study comparing finasteride plus tadalafil with finasteride plus placebo
Claus G Roehrborn, Adolfo Casabé, Sidney Glina, et al.
Postgraduate Medicine
|
July 12, 2021
Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies
Yvonne D'Arcy, Patrick Mantyh, Tony Yaksh, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 26, 2015
Tadalafil 5 mg once daily for the treatment of Asian men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: analyses of data pooled from three randomized, double-blind, placebo-controlled studies
Osamu Nishizawa, Masaki Yoshida, Masayuki Takeda, et al.
Page
of 12